Loading...
Maia Biotechnology Inc (MAIA) is not a good buy for a beginner investor with a long-term strategy at this time. The lack of positive financial performance, absence of significant trading trends, and neutral technical indicators do not support a strong entry point. Additionally, there are no recent positive catalysts or signals from proprietary trading tools to justify immediate action.
The MACD histogram is negative (-0.0823) and contracting, RSI is neutral at 47.005, and moving averages are converging, indicating a lack of clear direction. The stock is trading below the pivot level of 2.035, with support at 1.756 and resistance at 2.314. Overall, technical indicators suggest a neutral to slightly bearish trend.
NULL identified. No recent news, no significant hedge fund or insider activity, and no recent congress trading data.
The stock has a 70% chance of declining by -1.51% in the next day, -1.44% in the next week, and -2.76% in the next month. Financials show no revenue growth and a negative net income, despite YoY improvements.
In Q3 2025, the company reported no revenue growth (0% YoY), a net income of -$8.9M (up 225.41% YoY), and an EPS of -0.27 (up 145.45% YoY). Gross margin remains at 0%. The financials indicate improvement in losses but still show no profitability or revenue generation.
No analyst rating or price target changes available.
